Active Transport of Fluorescent P-Glycoprotein Substrates: Evaluation as Markers and Interaction with Inhibitors

By Wang E-j.   Casciano C.N.   Clement R.P.   Johnson W.W.  

Biochemical and Biophysical Research Communications, Vol. 289, Iss. 2, 2001-11 ,pp. : 580-585

Elsevier

Access to resources Recommend Favorite

Validation of membrane vesicle-based breast cancer resistance protein and multidrug resistance protein 2 assays to assess drug transport and the potential for drug––drug interaction to support regulatory submissions

By Elsby Robert   Smith Veronica   Fox Lisa   Stresser David   Butters Caroline   Sharma Pradeep   Surry Dominic D.  

Xenobiotica, Vol. 41, Iss. 9, 2011-09 ,pp. : 764-783

Informa Healthcare

Access to resources Recommend Favorite

Validation of cell-based OATP1B1 assays to assess drug transport and the potential for drug–drug interaction to support regulatory submissions

By Sharma P.   Holmes V. E.   Elsby R.   Lambert C.   Surry D.  

Xenobiotica, Vol. 40, Iss. 1, 2010-01 ,pp. : 24-37

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of P-glycoprotein in Caco-2 cells: Effects of herbal remedies frequently used by cancer patients

By Engdal S.   Nilsen O. G.  

Xenobiotica, Vol. 38, Iss. 6, 2008-06 ,pp. : 559-573

Informa Healthcare

Access to resources Recommend Favorite

The impact of P-glycoprotein mediated efflux on absorption of 11 sedating and less-sedating antihistamines using Caco-2 monolayers

By Crowe Andrew   Wright Cameron  

Xenobiotica, Vol. 42, Iss. 6, 2012-06 ,pp. : 538-549

Informa Healthcare

Access to resources Recommend Favorite